Mid cities Psychiatry
Mid cities Psychiatry
Mid cities Psychiatry
Schedule an Appointment
Patient Referral
Mid cities Psychiatry
Mid cities Psychiatry
  • (817) 488-8998
(817) 488-8998
Patient Referral
Schedule an Appointment
Patient Portal
(817) 488-8998
Patient Referral
Mid cities Psychiatry
Mid cities Psychiatry
Schedule an Appointment
Patient Portal

Rexulti (Brexpiprazole)

Dr Kazi, SeemaAuthor: Dr Kazi, Seema

Rexulti is the trade name for brexpiprazole, a drug used within the practice of psychiatry to help patients suffering from mental disorders such as major depressive disorder or schizophrenia. In practice, Rexulti is administered as additional treatment to antidepressants or as a separate medicine, depending on the case. Rexulti is one of the newest drugs, more specifically, it is an atypical antipsychotic which is developed not to block but to balance serotonin and dopamine levels in a person’s body.

The specific value of Rexulti in today’s practice is that it helps a person manage mood swings and thought disorders, as well as such symptoms as lack of interest and motivation to do anything. This way, Rexulti is considered a serotonin-dopamine activity modulator. Rexulti comes in different strengths and usually is used daily. Rexulti is a drug that might prove to be helpful when used properly.

Rexulti Classification

Rexulti falls into the category of atypical antipsychotics, commonly referred to as second generation antipsychotics. These drugs serve to be quite prevalent in the treatment of psychiatric conditions that include mood, perceptual, and behavioral disturbances. Unlike their predecessors, drugs in this group tend to work via several mechanisms and exhibit better tolerability. In general, Rexulti is considered one of those agents whose therapeutic effects target both serotonin and dopamine systems in order to produce a more comprehensive effect.

As can be seen, brexpiprazole (Rexulti) acts as a serotonin-dopamine activity modulator. Such a mechanism of action sets the drug apart from traditional receptor antagonists because rather than completely blocking receptor actions, they stimulate or reduce their activity as necessary. It is an important characteristic that determines the classification of Rexulti and accounts for the range of diseases this drug treats. As mentioned in the prescribing information, it belongs to antipsychotics and has both depressive and psychotic uses.

Rexulti Used For

The main use of Rexulti drug is the treatment of schizophrenia, schizoaffective disorders, and MDD. In the case of MDD, Rexulti is usually used in combination with other drugs in cases where patients fail to respond appropriately to antidepressants already being taken. This will ensure that patients obtain maximum benefit from the treatment. When used for the treatment of schizophrenia, Rexulti acts as a first-line treatment that will enable one to cope with delusions, hallucinations, and other symptoms.

In addition to helping in coping with delusions, Rexulti can be used to improve other functions, especially motivation and social skills. Although Rexulti is mainly used for the treatment of two conditions, there are cases where other aspects are considered before administering the drug. This is attributed to the flexibility that Rexulti offers due to its capability to modulate rather than completely inhibit neurotransmitters.

Indications and Usage

The following are some of the indicated uses of Rexulti which include; it is used as an augmentation therapy for adults diagnosed with major depressive disorders and as an anti-psychotic in the management of adult and adolescent cases of schizophrenia patients who are at least 13 years old. The drug is known to have the efficacy of treating psychotic symptoms and mood disorders.

In practice, Rexulti is used as medicine in cases where there is a need to supplement treatment with other forms of medicines to address certain symptoms of a patient’s condition. It helps in regulating thoughts of a person suffering from schizophrenia or schizoaffective disorders and lowers risks of relapse when administered consistently. psychiatric conditions differ from one individual to another hence treatment needs to be modified from time to time.

Dosage and Administration

The recommended dosage of Rexulti is one pill per day regardless of meals depending on the medical condition and individual reaction. When treating depression, the starting dose is relatively low, for example, 0.5 mg or 1 mg daily, which is gradually increased until the expected therapeutic effects are observed. The aim is to achieve adequate concentrations of the active substances in patients suffering from schizophrenia. Dosage adjustment is needed for people who have any form of liver and kidney dysfunction and individuals undergoing other medications.

Titration should be done carefully to ensure that the medication is both effective and tolerable. Doctors will incrementally escalate the amount of Rexulti until the desired results are attained. As you can see, the medication exists in several strengths, which makes it easy for the physician to customize treatment for each individual.

Rexulti 0.5 mg

It is normal for doctors to recommend a dosage of 0.5mg of Rexulti as an introductory dose, especially in patients suffering from major depressive disorder. The benefit of having a low starting dose is that any adverse effects will be reduced, giving the body time to get used to the drug.

Rexulti 1 mg

A Rexulti 1 mg dosage is used as part of the titration process, or can also act as the maintenance dosage for certain people. At this dosage level, improvement in mood, energy, and cognition will likely be seen. But, more changes are usually done depending on the response and tolerance of the drug.

Rexulti 2 mg

The Rexulti 2 mg dosage is generally taken by many people as the target dosage. It gives good effects without having severe side effects. This can be enough for many individuals but there are cases where more dosing needs to be done.

Rexulti Pill Identification

The Rexulti tablets come in different strengths, which are identifiable through unique characteristics in their color and printings. For instance, the weaker formulations such as the 0.25 mg and 0.5 mg tablets have a light coloration, whereas the stronger formulations like 2 mg have different colors ranging from green, purple, or white based on the strength. The Rexulti pills are printed with the letters BRX followed by the formulation strength, which helps to distinguish the drug.

The proper identification of the Rexulti tablet is essential to prevent medication errors since most individuals have other prescriptions. Patients are encouraged to verify the coloration and printings of the pill before taking the medication.

Warnings and Precautions

There are a number of vital warnings about Rexulti that must be taken into consideration while administering this medication. First, this medicine poses an additional risk of death for elderly individuals with psychosis related to dementia, where Rexulti is not indicated at all. Moreover, the drug might lead to the development of suicidal ideas and behaviors in younger patients during the initial period of treatment.

Among other precautions regarding Rexulti medicine use is its ability to affect metabolism through inducing such problems as weight gain, high blood sugar levels, and abnormal lipid metabolism. In addition, patients may suffer from such adverse events as akathisia, dizziness, and orthostatic hypotension. All this means that Rexulti should be monitored carefully; appropriate changes to the treatment regimen should be made on an individual basis.

Common Side Effects

Rexulti is quite safe; however, as with all psychiatric drugs, it does pose some risk of side effects. Among the most frequent side effects were noted as weight gain and akathisia (inner restlessness), both of which can be experienced in the early stages of therapy. Usually, these side effects are quite mild and may get better after the body gets used to the drug. Despite this, monitoring should still be done to avoid any possible side effects from interfering with a person’s everyday life.

Common Rexulti side effects include:

  • Weight gain
  • Akathisia (restlessness)
  • Headache
  • Fatigue
  • Nausea

These side effects usually aren’t too strong but, if persistent, can affect the course of therapy. It is likely that adjusting the dosage will help to alleviate symptoms.

Serious Side Effects

Despite being rarer, there are some severe adverse reactions that might occur with the use of Rexulti. Such effects are typical for all atypical antipsychotics, and therefore, they should be taken into account before using the medication. Clinicians recommend their patients and caregivers monitor the emergence of such adverse reactions, especially when the dosage is changed or in the first weeks of treatment.

Serious side effects of Rexulti may include:

  • Suicidal ideation and behavioral changes, especially among young people;
  • Neuroleptic malignant syndrome (NMS);
  • Tardive dyskinesia (uncontrollable movements);
  • Significant changes in metabolic indicators (hyperglycemia, dyslipidemia);
  • Orthostatic hypotension and syncope.

Such effects can become fatal if not detected early. Therefore, regular monitoring of a patient’s condition is necessary.

Pharmacokinetics

Rexulti (brexpiprazole) has pharmacokinetic characteristics that allow for a once-a-day dose of this agent. Brexpiprazole has an established pattern of absorption following its administration, where the concentration in blood builds up over time. The substance is metabolized predominantly by the liver through P450 enzymes, mainly CYP3A4 and CYP2D6. As a result, individual differences may affect its metabolism.

Metabolism, and thus pharmacokinetics, are impacted by other factors. For instance, the half-life of Rexulti makes it possible to maintain steady levels in the bloodstream and not experience any adverse effects of fluctuating concentrations. However, genetic predispositions, liver and kidney functioning, and other medications can affect the process, thus necessitating dose adjustments.

Risk Warnings

There are various risk factors associated with the administration of Rexulti, and some of them should be considered by clinicians prior to prescribing this drug. Firstly, Rexulti is contraindicated for the treatment of psychosis in elderly patients with dementia because it increases the risk of mortality. Second, Rexulti can lead to increased suicide risk in young patients when administered concomitantly with other antidepressants.

Apart from these significant risks, Rexulti can cause metabolic side effects, such as weight gain and high blood sugar levels. In addition, Rexulti can cause orthostatic hypotension and, therefore, an increased risk of falls. In light of the above, it is crucial for clinicians to conduct an initial evaluation of patients’ health and monitor their progress.

Contraindications

Rexulti is completely contraindicated in those who are known to have hypersensitivity or an allergy to either brexpiprazole or any component of the formulation. Possible allergic reactions may manifest as symptoms like rashes, swelling, hives or even rarely, anaphylaxis. Hence, it is very important that any past history of drug allergy be determined first prior to the use of the drug.

There are also other specific patient populations where caution should be exercised when considering the administration of Rexulti despite not being considered as absolute contraindications. Rexulti is not indicated for the management of psychosis related to dementia due to mortality risks associated with its use in this population. In complicated medical cases, one needs to carefully evaluate the safety of using Rexulti.

Drug Interactions

Rexulti metabolism occurs mainly through the cytochrome P450 enzyme system. Specifically, CYP3A4 and CYP2D6 enzymes play key roles. Therefore, drugs that act as inhibitors or inducers for these enzymes have a considerable impact on the metabolism of Rexulti. Inhibition will increase the concentrations of Rexulti, leading to adverse reactions while induction reduces the drug effectiveness through decreased Rexulti plasma concentration. Dosing modifications are necessary when Rexulti is combined with other medications.

Some common drug interactions to think about are:

  • CYP3A4 inhibitors (which can raise Rexulti levels)
  • CYP2D6 inhibitors (which need dose adjustments)
  • CYP3A4 inducers (which can make Rexulti less effective).

Because of these interactions, it is important for patients to tell their doctors about all the medications they take, including prescription and over-the-counter medicines and dietary supplements. Managing Rexulti drug interactions is important for making sure the drug is safe and works well.

Administration Guidelines

Revolta is usually administered according to prescription from a health professional and taken once per day, either with or without meals. Consistency is paramount in dosing for optimal efficacy and to maintain consistent drug levels within the system. Generally, Revolte treatment starts at a low dose and then gradually increases depending on clinical response and tolerance. People shouldn’t suddenly stop taking their medicine because it could have bad effects.

When a patient has other illnesses, especially ones that affect their organs of excretion, their dosage is changed. The drug’s metabolism depends highly on the activity of some cytochrome P450 enzymes and, therefore, requires close observation for drug interactions. Proper dosage ensures maximum benefits from the use of Revolta.

Use in Special Populations

Rexulti should be used with caution in certain subgroups because of physiological differences that could affect safety and effectiveness. For example, age, pregnancy, and pre-existing health conditions may change how the body breaks down and tolerates the drug. To make sure that the benefits outweigh the risks in every case, doctors usually tailor treatment plans based on these factors.

In reality, the importance of monitoring intensifies within these subgroups. Modifications in dosage, increased monitoring, and other measures may become required. Knowledge of how Rexulti acts in various subpopulations makes it possible for physicians to prescribe the drug safely and effectively.

Pregnancy

Rexulti must be administered to pregnant women with extreme care as exposure to the medication during the third trimester can cause extrapyramidal symptoms or withdrawal reactions in neonates, such as irritability, abnormal muscle tone, or difficulty feeding. For this reason, the drug is usually administered only when its benefits outweigh its potential risks.

Lactation

It is still unknown whether Rexulti is secreted into the breast milk of humans. In this regard, clinicians need to weigh the risks and benefits of either taking the medication or breast-feeding the infant.

Pediatric Use

Rexulti can be used on adolescents who are at least 13 years of age for treating schizophrenia or schizoaffective disorders. The safety and efficacy of this medication in pediatric patients under the age of 13 years are not fully determined. Rexulti should be used with caution in pediatric patients and should be closely monitored for any possible adverse effects.

Geriatric Use

In elderly individuals, especially those who suffer from dementia-related psychosis, using Rexulti increases the risk of death. This drug is not approved for this purpose in this patient population. Elderly patients are also more likely to experience adverse effects, such as orthostatic hypotension and sedation .

Clinical Benefits

Rexulti has multiple advantages in clinical practice that make it an important medication in current psychiatry. The action of Rexulti as a serotonin-dopamine activity modulator contributes to better regulation of neurotransmitters in the body, leading to improved mood and cognitive processes. When treating major depressive disorder, Rexulti is used as an auxiliary agent for antidepressant drugs when the effect of monotherapy is not satisfactory.

When treating schizophrenia, Rexulti contributes to decreasing both positive symptoms (hallucinations) and negative symptoms (social withdrawal, absence of motivation). In addition, the drug has a relatively acceptable tolerability index, which is higher than that of other antipsychotics.

Storage and Handling

Storage of Rexulti tablets requires that they be kept at normal room temperature, away from sources of high heat, moisture, and sunlight. Storage will help ensure the efficacy of the drug due to proper conditions that facilitate preservation. Rexulti should be kept within its packaging and inaccessible to children.

Moreover, any leftover or expired medication should be discarded in accordance with proper disposal protocols. Handling is important as it ensures efficacy while preventing potential misuse of the drug.

Drug Profile Rexulti FAQ’s

Yes, Rexulti is an atypical antipsychotic drug. It is a part of a new group of drugs which acts as partial agonists to control dopamine and serotonin neurotransmission in the brain. This mechanism is different from other antipsychotic drugs which act as antagonists to the receptors.

Initially, the drug may show its effects after 1 to 2 weeks. However, the patient needs to wait for several weeks before getting the complete benefits of the drug. For mental illnesses such as depression or schizophrenia, Rexulti is usually taken continuously for days because the symptoms gradually disappear upon continuous use.

Yes, Rexulti can be used in conjunction with antidepressant medications. This drug is used for treating patients with major depressive disorder as a supplemental drug with an antidepressant.

Rexulti can be associated with fatigue or tiredness in certain people. The effect varies; therefore, the patient may be sedated or not feel any change in wakefulness. In any case, it is suggested to pay attention to the body’s reaction and then start doing something demanding in terms of focus.

Conclusion

Rexulti (brexpiprazole) is a modern atypical antipsychotic medication used in the therapy of major depressive disorder, schizophrenia and schizoaffective disorders. Thanks to its special mechanism as a serotonin-dopamine activity modulator, this drug demonstrates a balanced action on the most complicated symptoms. In general, Rexulti belongs to a special class of psychotropic agents used to treat certain conditions. This article discusses Rexulti classification, its applications, dosage regimen, safety measures, and advantages for the patient’s health.

(817) 488-8998
Patient Portal
Schedule an Appointment
Patient Referral

Subscribe to Our Newsletter